Ascendis to Share Its Latest Endocrinology Rare Disease Data at ENDO 2025 - Stock Titan
Yesterday • Google News
Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally..
Yesterday • Google News
4 days ago • Google News
4 days ago • Google News